|
|
 disability Information - November 21, 2008
| There's good news for people who fear aging. According to U.S. research, running can actually help slow down the aging process. A team from Stanford University Medical Center here have discovered that elderly people who are long-term joggers were less likely to die from medical conditions such as cancer as compared with those who are not joggers. They were also healthier and had fewer disabilities | | An Indian court on Monday refused a mother's plea to abort a 26-week fetus with a serious heart defect, saying the law does not permit such late-term abortions. The 31-year-old mother, Niketa Mehta, and her husband Haresh found out after 24 weeks that the fetus had a complete congenital heart blockage and malpositioned arteries that could, doctors told them, require a pacemaker implantation soon after birth | | Outside medical experts for the Food and Drug Administration (FDA) on Tuesday recommended approval of Roche Holding AG's drug Actemra to treat moderate to severe rheumatoid arthritis. The drug is more effective at reducing symptoms of rheumatoid arthritis than existing biologic agents, which are dominated by a type of drug known as anti-TNFs. The new drug will target the drug for patients who failed anti-TNFs, such as Johnson & Johnson's drug Remicade and Abbott Laboratories' Humira, DowJones reported | | Parents who care for mentally-challenged children are prone to develop weak immune systems due to stress, new research suggests. The study concluded that such parents should be offered a better support system. Researchers at Birmingham University analyzed 60 parents who received the pneumococcal vaccine as part of the study. Half of them had children with developmental disabilities | | A combination of two drugs, Enbrel and methotrexate, when given to patients in the early stages of rheumatoid arthritis has shown to halt progression of joint damage, a new study has found. Researchers from the University of Leeds in England analysed 542 rheumatoid arthritis patients in Europe, Latin America, Asia, and Australia for two years. All of the patients took methotrexate pills along with a weekly shot of the biologic drug Enbrel; others got a placebo shot, WebMD reported | |
|
|